A 64-year-old man was initially treated with adriamycin, carmustine, CY and melphalan for symptomatic multiple myeloma. Following a poor response the patient was switched to oral melphalan, which was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback